Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains ...

Abstract TAR DNA-binding protein 43 (TDP-43) inclusions are pathological hallmarks of patients with frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Loss of TDP-43 in zebrafish engenders a severe muscle and vascular phenotype with a concomitant elevation of filamin C (FLNC) levels, an observation confirmed in the frontal cortex of FTLD-TDP patients. Here, we aimed to further assess the contribution of FLNC to frontotemporal dementia (FTD) etiology. We conducted a mutational screening of FLNC in a cohort of 529 unrelated Belgian FTD and FTD-ALS patients, and a c... Mehr ...

Verfasser: Janssens, Jonathan
Philtjens, Stéphanie
Kleinberger, Gernot
Mossevelde, Sara Van
Zee, Julie Van Der
Cacace, Rita
Engelborghs, Sebastiaan
Sieben, Anne
Banzhaf-Strathmann, Julia
Lubina Dillen
Merlin, Céline
Cuijt, Ivy
Robberecht, Caroline
Schmid, Bettina
Santens, Patrick
Ivanoiu, Adrian
Vandenbulcke, Mathieu
Vandenberghe, Rik
Cras, Patrick
Deyn, Peter De
Jean-Jacques Martin
Maudsley, Stuart
Haass, Christian
Cruts, Marc
Broeckhoven, Christine Van
Dokumenttyp: Artikel
Erscheinungsdatum: 2015
Verlag/Hrsg.: Figshare
Schlagwörter: Biochemistry / Medicine / Cell Biology / Genetics / FOS: Biological sciences / Molecular Biology / Neuroscience / Immunology / FOS: Clinical medicine / 69999 Biological Sciences not elsewhere classified / Developmental Biology / Science Policy
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-29300548
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dx.doi.org/10.6084/m9.figshare.c.3627980

Abstract TAR DNA-binding protein 43 (TDP-43) inclusions are pathological hallmarks of patients with frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Loss of TDP-43 in zebrafish engenders a severe muscle and vascular phenotype with a concomitant elevation of filamin C (FLNC) levels, an observation confirmed in the frontal cortex of FTLD-TDP patients. Here, we aimed to further assess the contribution of FLNC to frontotemporal dementia (FTD) etiology. We conducted a mutational screening of FLNC in a cohort of 529 unrelated Belgian FTD and FTD-ALS patients, and a control cohort of 920 unrelated and age-matched individuals. Additionally we performed an in-depth characterization of FLNC expression levels in FTD patients and a murine FTD model. In total 68 missense variants were identified of which 19 (MAF C) loss-of-function mutation. Increased FLNC levels were, to a lesser extent, also identified in a FLNC p.V831I variant carrier and in FTD patients with the p.R159H mutation in ...